Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration.

Gorusupudi A, Nelson K, Bernstein PS.

Adv Nutr. 2017 Jan 17;8(1):40-53. doi: 10.3945/an.116.013177. Review.

PMID:
28096126
2.

Intravenous Treatment with a Long-Chain Omega-3 Lipid Emulsion Provides Neuroprotection in a Murine Model of Ischemic Stroke - A Pilot Study.

Berressem D, Koch K, Franke N, Klein J, Eckert GP.

PLoS One. 2016 Nov 30;11(11):e0167329. doi: 10.1371/journal.pone.0167329.

3.

Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease.

Bühler AD, Bucher F, Augustynik M, Wöhrl J, Martin G, Schlunck G, Agostini H, Böhringer D, Pütz G, Stahl A.

BMC Ophthalmol. 2016 Sep 5;16(1):159. doi: 10.1186/s12886-016-0335-9.

4.

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease.

Heras-Sandoval D, Pedraza-Chaverri J, Pérez-Rojas JM.

J Neuroinflammation. 2016 Mar 10;13(1):61. doi: 10.1186/s12974-016-0525-7. Review.

5.

Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A.

Quek DQ, Nguyen LN, Fan H, Silver DL.

J Biol Chem. 2016 Apr 29;291(18):9383-94. doi: 10.1074/jbc.M116.721035.

PMID:
26945070
6.

Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers.

Gorusupudi A, Liu A, Hageman GS, Bernstein PS.

J Lipid Res. 2016 Mar;57(3):499-508. doi: 10.1194/jlr.P065540.

7.

The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease.

Czapski GA, Czubowicz K, Strosznajder JB, Strosznajder RP.

Neurochem Res. 2016 Feb;41(1-2):243-57. doi: 10.1007/s11064-015-1776-x.

8.

Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease.

Thomas J, Thomas CJ, Radcliffe J, Itsiopoulos C.

Biomed Res Int. 2015;2015:172801. doi: 10.1155/2015/172801. Review.

9.

Dietary supplement enriched in antioxidants and omega-3 protects from progressive light-induced retinal degeneration.

Ramchani-Ben Othman K, Cercy C, Amri M, Doly M, Ranchon-Cole I.

PLoS One. 2015 Jun 4;10(6):e0128395. doi: 10.1371/journal.pone.0128395.

10.

Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes.

Shevalye H, Yorek MS, Coppey LJ, Holmes A, Harper MM, Kardon RH, Yorek MA.

J Neurophysiol. 2015 Jul;114(1):199-208. doi: 10.1152/jn.00224.2015.

11.

Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Liu JJ, Green P, John Mann J, Rapoport SI, Sublette ME.

Brain Res. 2015 Feb 9;1597:220-46. doi: 10.1016/j.brainres.2014.11.059. Review.

12.

Post-ischemic inflammation regulates neural damage and protection.

Shichita T, Ito M, Yoshimura A.

Front Cell Neurosci. 2014 Oct 14;8:319. doi: 10.3389/fncel.2014.00319. Review.

13.

Mammalian lipoxygenases and their biological relevance.

Kuhn H, Banthiya S, van Leyen K.

Biochim Biophys Acta. 2015 Apr;1851(4):308-30. doi: 10.1016/j.bbalip.2014.10.002. Review.

14.

Dietary ω-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis.

Fitzgerald KC, O'Reilly ÉJ, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

JAMA Neurol. 2014 Sep;71(9):1102-10. doi: 10.1001/jamaneurol.2014.1214.

15.

Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging.

Ryan VH, Primiani CT, Rao JS, Ahn K, Rapoport SI, Blanchard H.

PLoS One. 2014 Jun 25;9(6):e100858. doi: 10.1371/journal.pone.0100858.

16.

Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease.

Fonteh AN, Cipolla M, Chiang J, Arakaki X, Harrington MG.

PLoS One. 2014 Jun 23;9(6):e100519. doi: 10.1371/journal.pone.0100519.

17.

Emerging targets in neuroinflammation-driven chronic pain.

Ji RR, Xu ZZ, Gao YJ.

Nat Rev Drug Discov. 2014 Jul;13(7):533-48. doi: 10.1038/nrd4334. Review.

18.

ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion.

Barrett EC, McBurney MI, Ciappio ED.

Adv Nutr. 2014 May 14;5(3):268-77. doi: 10.3945/an.113.005280. Review.

19.

Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.

Figueroa JD, De Leon M.

Mol Neurobiol. 2014 Aug;50(1):197-213. doi: 10.1007/s12035-014-8701-1.

20.

The emerging role of nutrition in Parkinson's disease.

Seidl SE, Santiago JA, Bilyk H, Potashkin JA.

Front Aging Neurosci. 2014 Mar 7;6:36. doi: 10.3389/fnagi.2014.00036. Review.

Supplemental Content

Support Center